Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Financing the Deal


 
(L-R): Moderator Tom Wylly is joined by investment experts Justin Ishbia, Nancy-Ann Deparle, Jeffrey Crisan and Casey West. Photo: © 2019, Donn Jones.

NHCC Panelists Discuss Investment Opportunities

On May 22, the Nashville Health Care Council hosted a panel discussion on private equity investment trends and strategies within the healthcare industry. More than 300 members attended the afternoon event at the Loews Vanderbilt Plaza to learn more about the state of the market, M&A activity, and the outlook for funding the growth of Nashville's $92 billion healthcare industry.

Tom Wylly, senior partner at Brentwood Capital Advisors, moderated the distinguished panel, which included Jeffrey R. Crisan, managing partner, Silversmith Capital Partners; Nancy-Ann DeParle, partner, Consonance Capital; Justin Ishbia, managing partner, Shore Capital; and Casey West, managing partner, SSM Partners.

The panel started off with a discussion of trends in deal activity for new acquisitions. Crisan began with an observation about market similarities between 2018 and 2019, noting the macroeconomic factors are consistent across both years. While 2019 has gotten off to a slower start in the first quarter, much like 2018, he said he expects it will return to 2018 levels over the course of the year. The panelists generally agreed, and all expect to see valuable market opportunities this year.

It was noted that many investment firms are approaching deals with younger companies, strengthening the existing management teams at those companies, and developing three- to five-year plans focusing on sales and growth. Panelists said both short-term and long-term value creation, as well as company culture, talent, hiring and collaboration, are key components of the acquisition strategy.

Additionally, panelists shared insights on sub-industries within healthcare that are on the rise. DeParle spoke of Consonance Capital's interest in behavioral health and hospice, and Ishbia discussed Shore Capital's interest in exploring the opioid addiction treatment space, preventive medicine, animal health, orthodontics, women's health, IVF and FDA compliance, and consulting.

Crisan shared an observation on healthcare IT by stating, "There's been an evolution in the data and analytics market. Data and analytics is no longer just early stage companies. In fact, we have invested in three data and analytics companies that have achieved profitability." West added his firm has an interest in companies deploying technology that can improve processes.

When identifying companies with which to partner, panelists agreed on two critical prerequisites: company culture and sector knowledge. "To me, sector knowledge is important because it allows you to develop relationships without having to explain something multiple times," DeParle said. "You want to look for people who understand a basic knowledge of the industry."

Wylly chimed in saying, "Many companies treat capital raise as a transaction versus the beginning of a relationship. Focus secondarily on price and terms, and instead shift the attention on culture, business objectives, and decision-making that results in fruitful relationships and trust building."

While the panelists represented firms from across the country, all have deep knowledge and ties to Nashville's healthcare ecosystem. Each panelist agreed the city has unique strengths. With two Nashville companies having already gone live with IPOs this year - Change Healthcare and Smile Direct Club - each panelist expressed considerable optimism for this year and years to come.

"I think Nashville is on a run that will continue for the next 20 or 30 years," West said. "What sets Nashville apart is the talent," Ishbia added. "The people here are what make the difference."

WEB:

Nashville Health Care Council

 
Share:

Related Articles:


Recent Articles

Study Finds Certain Genetic Test Not Useful in Predicting Heart Disease Risk

A Polygenic Risk Score -- a genetic assessment that doctors have hoped could predict coronary heart disease (CHD) in patients -- has been found not to be a useful predictive biomarker for disease risk, according to a Vanderbilt study published in the Journal of the American Medical Association.

Read More

Tennessee Infants Exposed to Hep C at Birth Often Not Tested for Virus

Most Tennessee infants exposed to hepatitis C at birth are not later tested to see if they acquired the virus, according to a study by researchers at Monroe Carell Jr. Children's Hospital at Vanderbilt and the Vanderbilt Center for Child Health Policy.

Read More

THA, TMA, TNA Outline Legislative Priorities

With the Tennessee General Assembly back in full swing, the state's major healthcare associations outline 2020 priorities.

Read More

Cardiac Innovation in Nashville

From transplants to trials, Nashville hospitals are leading the way in cardiac care.

Read More

A Modern Love Story: Where Technology, Healthcare & Construction Go Hand-in-Hand

Technology has changed every aspect of our lives. In fact, I had a healthy laugh a few weeks ago when I showed my children an old rotary phone and, get this, they did not know what it was.

Read More

Reeves/Smith Bill to Prevent Next Generation of Nicotine Addiction Garners Broad Industry Support

In late January, a group of more than 25 organizations from across Tennessee announced their support for legislation that seeks to prevent the next generation of nicotine addicts in the state.

Read More

Physician Spotlight: A Heart for Healing

TriStar Summit cardiologist Kristen Kerr is passionate about education, improving outcomes in women's heart health.

Read More

Heart Monitor

Read More

Ifetroban for Treating DMD-Associated Cardiomyopathy

Following successful preclinical trials and FDA funding, Cumberland Pharmaceuticals is preparing to launch a new Phase II trial of ifetroban to treat cardiomyopathy in Duchenne Muscular Dystrophy patients.

Read More

Endocrine Society Celebrates Progress from Bench to Bedside

Endocrine Society Chief Professional & Clinical Affairs Officer Robert Lash, MD, discusses the field, annual meeting, road shows and more.

Read More

Email Print
 
 

 

 


Tags:
Casey West, Financing the Deal, Healthcare Investment, Jeffrey Crisan, Justin Ishbia, Nancy-Ann Deparle, Nashville Health Care Council, Tom Wylly
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: